# Thomas Elung‐Jensen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/thomas-elung-jensen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 302 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 11 |
| i10-index | 12 |
| Last Known Institution | Rigshospitalet |
| OpenAlex ID | https://openalex.org/A5022001466 |
| Works | 22 |

## Researcher papers

- [Moderate Antiproteinuric Effect of Add-On Aldosterone Blockade with Eplerenone in Non-Diabetic Chronic Kidney Disease. A Randomized Cross-Over Study](https://scholariq.org/papers/moderate-antiproteinuric-effect-of-add-on-aldosterone-blockade-with-eplerenone/)
- [Eplerenone Attenuates Pulse Wave Reflection in Chronic Kidney Disease Stage 3–4 - A Randomized Controlled Study](https://scholariq.org/papers/eplerenone-attenuates-pulse-wave-reflection-in-chronic-kidney-disease-stage-3-4/)
- [Retraining for prevention of peritonitis in peritoneal dialysis patients: A randomized controlled trial](https://scholariq.org/papers/retraining-for-prevention-of-peritonitis-in-peritoneal-dialysis-patients-a/)
- [Silencing of Renal DNaseI in Murine Lupus Nephritis Imposes Exposure of Large Chromatin Fragments and Activation of Toll Like Receptors and the Clec4e](https://scholariq.org/papers/silencing-of-renal-dnasei-in-murine-lupus-nephritis-imposes-exposure-of-large/)
- [Longitudinal observations on circadian blood pressure variation in chronic kidney disease stages 3-5](https://scholariq.org/papers/longitudinal-observations-on-circadian-blood-pressure-variation-in-chronic/)
- [Impact of the Tumor Necrosis Factor Receptor-Associated Protein 1 (Trap1) on Renal DNaseI Shutdown and on Progression of Murine and Human Lupus Nephritis](https://scholariq.org/papers/impact-of-the-tumor-necrosis-factor-receptor-associated-protein-1-trap1-on-renal/)
- [Adrenal insufficiency in kidney transplant patients during low-dose prednisolone therapy: a cross-sectional case–control study](https://scholariq.org/papers/adrenal-insufficiency-in-kidney-transplant-patients-during-low-dose-prednisolone/)
- [Blood pressure response to conventional and low‐dose enalapril in chronic renal failure](https://scholariq.org/papers/blood-pressure-response-to-conventional-and-low-dose-enalapril-in-chronic-renal/)
- [Enalapril dosage in progressive chronic nephropathy: a randomised, controlled trial](https://scholariq.org/papers/enalapril-dosage-in-progressive-chronic-nephropathy-a-randomised-controlled/)
- [Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring](https://scholariq.org/papers/hemoglobin-a1c-and-fructosamine-evaluated-in-patients-with-type-2-diabetes/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [Rigshospitalet](https://scholariq.org/institutions/rigshospitalet/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.